BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25259568)

  • 1. Co-prevalence of other tumors in patients harboring pituitary tumors.
    Couldwell WT; Cannon-Albright LA
    J Neurosurg; 2014 Dec; 121(6):1474-7. PubMed ID: 25259568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A heritable predisposition to pituitary tumors.
    Couldwell WT; Cannon-Albright L
    Pituitary; 2010 Jun; 13(2):130-7. PubMed ID: 20012699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
    Hummel S; Kohlmann W; Kollmeyer TM; Jenkins R; Sonnen J; Palmer CA; Colman H; Abbott D; Cannon-Albright L; Cohen AL
    BMC Cancer; 2019 Mar; 19(1):190. PubMed ID: 30823903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk for other cancers in individuals with Ewing sarcoma and their relatives.
    Abbott D; O'Brien S; Farnham JM; Young EL; Yap J; Jones K; Lessnick SL; Randall RL; Schiffman JD; Cannon-Albright LA
    Cancer Med; 2019 Dec; 8(18):7924-7930. PubMed ID: 31670911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familiality in brain tumors.
    Blumenthal DT; Cannon-Albright LA
    Neurology; 2008 Sep; 71(13):1015-20. PubMed ID: 18809838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A familial component to human rectal cancer, independent of colon cancer risk.
    Maul JS; Burt RW; Cannon-Albright LA
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1080-4. PubMed ID: 17625976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy.
    Abbott D; Johnson NE; Cannon-Albright LA
    Muscle Nerve; 2016 Oct; 54(4):783-5. PubMed ID: 27064430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utah Population Database: a tool to study the hereditary element of nonsyndromic neurosurgical diseases.
    Niazi TN; Cannon-Albright LA; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E1. PubMed ID: 20043712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer histologic subtypes show excess familial clustering.
    Henry NL; Cannon-Albright LA
    Cancer; 2019 Sep; 125(18):3131-3138. PubMed ID: 31120568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Risk in Patients With Carcinoma of Unknown Primary.
    Samadder NJ; Smith KR; Hanson H; Pimentel R; Wong J; Boucher K; Akerley W; Gilcrease G; Ulrich CM; Burt RW; Curtin K
    JAMA Oncol; 2016 Mar; 2(3):340-6. PubMed ID: 26863281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial clustering of endometrial cancer in a well-defined population.
    Seger HM; Soisson AP; Dodson MK; Rowe KG; Cannon-Albright LA
    Gynecol Oncol; 2011 Jul; 122(1):75-8. PubMed ID: 21514633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based risk assessment for other cancers in relatives of hereditary prostate cancer (HPC) cases.
    Albright LA; Schwab A; Camp NJ; Farnham JS; Thomas A
    Prostate; 2005 Sep; 64(4):347-55. PubMed ID: 15754348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of an Inherited Predisposition for Spinal Cord Tumors.
    Spiker WR; Brodke DS; Goz V; Lawrence B; Teerlink CC; Cannon-Albright LA
    Global Spine J; 2018 Jun; 8(4):340-344. PubMed ID: 29977717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.
    Cannon-Albright LA; Carr SR; Akerley W
    J Thorac Oncol; 2019 Jul; 14(7):1184-1191. PubMed ID: 31075544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer risk prediction based on complete prostate cancer family history.
    Albright F; Stephenson RA; Agarwal N; Teerlink CC; Lowrance WT; Farnham JM; Albright LA
    Prostate; 2015 Mar; 75(4):390-8. PubMed ID: 25408531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
    Goldgar DE; Easton DF; Cannon-Albright LA; Skolnick MH
    J Natl Cancer Inst; 1994 Nov; 86(21):1600-8. PubMed ID: 7932824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familiality of cardiovascular mortality in end-stage renal disease patients.
    Naiman N; Cheung AK; Goldfarb-Rumyantzev AS
    Am J Nephrol; 2009; 29(3):237-43. PubMed ID: 18799871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.
    Samadder NJ; Curtin K; Wong J; Tuohy TM; Mineau GP; Smith KR; Pimentel R; Pappas L; Boucher K; Garrido-Laguna I; Provenzale D; Burt RW
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2078-84.e1-2. PubMed ID: 24768809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database.
    Slattery ML; Kerber RA
    JAMA; 1993 Oct; 270(13):1563-8. PubMed ID: 8371466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial clustering of oropharyngeal squamous cell carcinoma in the Utah population.
    Monroe MM; Hashibe M; Orb Q; Alt J; Buchmann L; Hunt J; Cannon-Albright LA
    Head Neck; 2018 Feb; 40(2):384-393. PubMed ID: 29024178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.